6.67
+0.94(+16.40%)
Currency In USD
Address
433 Plaza Real
Washington, FL 33432
United States of America
Phone
561 709 3034
Website
Sector
Basic Materials
Industry
Chemicals
Employees
136
First IPO Date
November 10, 2022
| Name | Title | Pay | Year Born |
| Mr. Robert Ainscow | Chief Operating Officer & Interim Chief Executive Officer | 490,000 | 1976 |
| Dr. Gerdus Kemp M.D., Ph.D. | Medical Director & Chief Executive Officer of Pet Labs | 0 | N/A |
| Ms. Heather Kiessling | Chief Financial Officer | 600,000 | 1965 |
| Mr. Paul Elliot Mann C.F.A. | Executive Chairman | 1.01M | 1976 |
| Mr. William Eden M.B.E. | Global Head of HR & Director UK Nuclear Operations | 0 | N/A |
| Dr. Xandra van Heerden Ph.D. | Head of Research & Development | 0 | N/A |
| Mr. Hendrik T. van Wyk | Head of Engineering | 0 | N/A |
| Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | Chief Technology Officer | 0 | 1961 |
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.